logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Ponesimod CAS 854107-55-4

Ponesimod CAS 854107-55-4

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 854107-55-4

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
854107-55-4
Appearance::
White To Beige Powder
Molecular Formula::
C23H25ClN2O4S
Molecular Weight::
460.97400
EINECS NO::
848-887-0
MDL NO::
NA
CAS NO::
854107-55-4
Appearance::
White To Beige Powder
Molecular Formula::
C23H25ClN2O4S
Molecular Weight::
460.97400
EINECS NO::
848-887-0
MDL NO::
NA
Ponesimod CAS 854107-55-4

Product Description:

Product Name: ponesimod CAS NO: 854107-55-4

 

 

 

 

Synonyms:

Liraglutide [usan:inn];Liraglutidum;Liraglutidum [inn-latin];

N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine) glp-1-(7-37)-peptide;

 

 

 

 

Chemical & Physical Properties:

Appearance: White to beige powder

Assay: ≥98.0%

Density: 1.30±0.1 g/cm3 (Predicted)

Boiling Point: 658.0±65.0℃(Predicted)

 

 

 

Ponesimod (INN, codenamed ACT-128800) is an experimental drug for the treatment of multiple sclerosis (MS) and psoriasis. It is being developed by Actelion.

 

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.